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Abstract
Background: IEC-18 cells are a non-transformed, immortal cell line derived from juvenile rat ileal
crypt cells. They may have experimental advantages over tumor-derived gastrointestinal lineages,
including preservation of phenotype, normal endocrine responses and retention of differentiation
potential. However, their proclivity for spontaneous differentiation / transformation may be
stereotypical and could represent a more profound experimental confounder than previously
realized. We hypothesized that IEC-18 cells spontaneously diverge towards a uniform mixture of
epigenetic fates, with corresponding phenotypes, rather than persist as a single progenitor lineage.
Results: IEC-18 cells were cultured for 72 hours in serum free media (SFM), with and without
various insulin-like growth factor agonists to differentially boost the basal rate of proliferation. A
strategy was employed to identify constitutive genes as markers of divergent fates through gene
array analysis by cross-referencing fold-change trends for individual genes against crypt cell
abundance in each treatment. We then confirmed the cell-specific phenotype by
immunolocalization of proteins corresponding to those genes. The majority of IEC-18 cells in SFM
alone had a loss in expression of the adenomatous polyposis coli (APC) gene at the mRNA and
protein levels, consistent with adenoma-like transformation. In addition, a small subset of cells
expressed the serotonin receptor 2A gene and had neuroendocrine-like morphology.
Conclusions: IEC-18 cells commonly undergo a change in cell fate prior to reaching confluence.
The most common fate switch that we were able to detect correlates with a down regulation of
the APC gene and transformation into an adenoma-like phenotype.
Background
In the last quarter century, more than five hundred pub-
lished manuscripts contained experiments using the pop-
ular rat crypt cell lines IEC-6 and IEC-18 originally
established by Quaroni and Isselbacher in 1978 and 1981
[1,2]. These lineages have stood the test of time as being
two of the most reliable and phenotypically well-pre-
served gastrointestinal cell lines to date. In our lab, we uti-
lize the IEC-18 lineage because it is more robust in serum-
restricted conditions and, in our experience, it is more
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enterocyte physiology than cell lineages derived from
colonic tumors.
One of the more exciting aspects of IEC-18 cells is their
capacity to retain the crypt cell phenotype as well as the
continued potential for differentiation/maturation into
enterocytes [3-5]. However, as we have worked with this
lineage over the years, the rare but unmistakable mor-
phology of an occasional neuroendocrine-like cell, the
suspicious frothiness of a possible paneth-like cell and the
rare giant vacuole of a goblet cell precursor have
prompted us to wonder how prevalent spontaneous dif-
ferentiation towards other lineages and/or transformants
might be (especially in serum-restricted conditions).
This is a fairly crucial experimental question because
serum-restricted conditions allow the tightest experimen-
tal rigor but may drive IECs towards altered cell fates,
potentially introducing uncontrolled experimental con-
founders. Until recently, we did not have the necessary
tools with which to determine more subtle epigenetic
divergences in IECs. Our current investigation uses a novel
strategy to demonstrate that spontaneous cell fate diver-
gence is not only highly prevalent in IEC-18 cells, but it is
fairly uniform and therefore a predictable confounder for
gene array studies in this cell line.
Results
Initial characterization of IEC-18 culture heterotypy using 
immunolocalization
We have recently discovered a novel antigen localization
pattern by using anti-carboxyl IGF binding protein-2
(IGFBP-2) antibody (to an antigen which we call C2) to
demonstrate a multivesicular pattern in some IEC-18 cells
but not in others that are immediately adjacent (illus-
trated in Figure 1A). We note that anti-amino IGFBP-2
showed no staining in IEC-18 cells and that pretreatment
with synthetic antigen abolished C2 staining (data not
shown), confirming that C2 is a carboxyl fragment of
IGFBP-2. For the purpose of this study, we wanted to
determine whether or not this heterotypy represented cell
fate divergence or systemic pleiomorphism.
To further characterize the observed heterotypy, we exam-
ined IEC-18 cells with anti-actin antibody in IEC-18 cells
without performing antigen retrieval and allowing the
detection reaction to proceed until only a limited amount
of staining is seen. When used with the right antibody,
this technique is a means to visualize dynamic portions of
actin filaments, such as stress fibers and the proximal ends
of microvilli, because they lack the actin binding proteins
that obscure the antigen. If the reaction is allowed to con-
tinue, eventually all actin filaments will stain. In the ver-
sion that we use, the assay is a qualitative assessment of
cytoskeletal turnover when we are comparing two adja-
cent cells (because both cells had exactly the same condi-
tions for detection of actin). Both stress fibers and
microvilli are heavily stained and appear to have high
turnover rates in cells that have C2 staining, but not in
those without it (Figure 1B). We note that the punctate
dots of filamentous-actin corresponded with small micro-
villi in C2 positive cells and that the C2 negative cells had
a paucity of microvilli on their surface – which was con-
firmed by focusing up and down the shafts of the micro-
villi (data not shown).
IEC-18 cells spontaneously lose C2 staining prior to 
confluence, despite 10% FBS
When IEC-18 cells were plated at variable densities in
10% fetal bovine serum (FBS), we saw that all crypt cells
were initially positive for C2 staining, but with increasing
density there were increasing numbers of C2 negative cells
(Figure 1C). We also saw that C2 positive cells had
increased staining intensity as they approached conflu-
ence. This experiment demonstrates two important
points: first, that loss of C2 staining begins before conflu-
ence and second, that it can occur with comparable prev-
alence in the presence of FBS as it does in serum free
media (SFM).
C2 positive cells and C2 negative cells are both capable of 
phenotype preservation during proliferation
To determine if the C2 positive and negative IEC-18 cells
were each capable of phenotype preservation during pro-
liferation, IGFBP-2 stained cells on coverslips were
searched for mitotic cells in the stage of cytokinesis and
their images were captured by digital photomicroscopy (n
= 6 cell pairs for each phenotype). In each case, all daugh-
ter cells had the same phenotype as their sister, confirm-
ing that both the C2 positive and C2 negative phenotypes
are conserved in subsequent cycles of mitosis (representa-
tive examples in Figure 1D).
C2 positive cell abundance is increased in proportion to 
the efficacy of IGF agonist treatment
Because IEC-18 cells grow best in the presence of high
dose insulin, we suspected that crypt cell proliferation was
dependent upon IGF receptor stimulation. In general, dif-
ferentiated and benignly transformed epithelial cells are
less likely to proliferate upon reaching confluence, so we
sought to preferentially drive crypt cell proliferation in a
graded fashion using different IGF receptor agonists (Fig-
ure 2). IGF-II analog, a weak agonist, reduced the crypt
cell abundance while NBI 31772 (an agent that displaces
IGFs from IGFBPs) increased it significantly and R3-IGF-I
doubled the number of crypt cells per 10X field (also
highly significant) while none of the treatments signifi-
cantly altered the abundance of C2 negative cells. This
strategy allowed us to systematically skew the cellPage 2 of 11
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whether C2 positive cells were epigenetically divergent.
Our gene array methodology identified four candidate 
genes as potential markers of cell fate divergence in IEC-
18 culture
Eleven genes met our criteria for a significant fold change,
four were positively correlated with crypt cell abundance
and seven were inversely correlated (Figure 3). Of these
first pass candidates, only six showed the appropriate fold
trends across all treatment conditions, consistent with our
hypothesis of constitutive expression that could reflect
divergent cell fates. Of these six, one was found to have a
significant difference between IGF-II analog and SFM, sug-
gesting a direct treatment effect by IGF agonists but not by
NBI 31772 (dithiolethione-inducible gene 1). Enzymatic
glycosylation-regulating gene is known to be an insulin
responsive gene and was also excluded because of the high
probability of a direct effect by our IGF agonists [6]. Of the
four remaining candidates, one (brain acyl CoA
Immuno-characterization of IEC-18 cell heterotypyFigure 1
Immuno-characterization of IEC-18 cell heterotypy. A: Carboxyl IGFBP-2 immunostaining of the sequestered C2 fragment in 
cells with a preserved crypt cell phenotype but not in others. B: F-actin immunostaining (performed without antigen retrieval 
to visualize dynamic actin filaments) demonstrates intense staining in crypt cells but not in others. C: Cells plated at variable 
density with 10% FBS start out as weakly C2 positive (i) but have a progressive loss of C2 immunostaining prior to confluence 
(ii-iv). D: Immunolocalization of the C2 antigen demonstrates that both C2 positive (i) and C2 negative (ii) cells preserve their 
phenotypes during proliferation. E-F: Control immunolocalization using the IGF type 2 receptor (E) as a prelysosome-localized 
antigen and villin (F) as a cytoplasmic-localized antigen to demonstrate that both intravesicular and cytoplasmic antigens can be 
evenly detected throughout IEC culture.
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ground levels in the SFM, IGF-II analog and NBI 31772
treatment conditions (defined as 10 arbitrary fluorescent
units) and has had a relatively limited characterization in
the literature [7-9]. We saw no obvious means for obtain-
ing or generating an antibody to it and thought it unlikely
to be a robust marker at the protein level, in large part
because its message has only been found in brain thus far.
Another had high homology with the EGF family and is
currently a predicted protein based on genomic sequence
[10]. However, the two remaining candidate genes we
pulled out were well-characterized gut-related proteins
(APC and 5-HT2A).
Immunolocalization for 5-HT2A and APC revealed 2 
divergent phenotypes within IEC-18 cell culture
Western blots using antibodies against APC and 5-HT2A
in IEC-18 cell lysates revealed staining of the appropriate
sized band for each (Figure 4). In the case of APC, there
were several discrete smaller bands which were inversely
proportional in abundance to the 300 kD full-sized pro-
tein (consistent with proteolytic fragments) when com-
pared across multiple samples (data not shown). In the
case of 5-HT2A, there was a single 28 kD band that was
faint, suggesting relatively low abundance. Both antibod-
ies were deemed suitable for immunolocalization.
Immunolocalization for APC revealed that C2 positive
cells also had intense APC staining whereas C2 negative
cells either had limited or no APC staining (Figure 5A).
This finding is in keeping with our gene array analysis and
suggests that there is substantial and wide spread diver-
gence of IEC-18 crypt cells away from the crypt cell phe-
notype and towards an adenoma-like transformation.
Immunolocalization for 5-HT2A demonstrated a second
cell phenotype (Figure 5B,C and 5D). We had previously
noted rare neuroendocrine-like morphology character-
ized by spindle-shaped cells with bipolar, dendritic arbors
(unpublished findings), however with 5-HT2A immunos-
taining we found a mean of 5 positively stained cells per
coverslip of confluent cells (n = 6 coverslips of confluent
Mean number of C2 positive and C2 negative cells for each treatment conditionFigure 2
Mean number of C2 positive and C2 negative cells for each treatment condition. C2 positive cells are boxed in gray and C2 
negative cells in stripes. Note that IGF-II analog reduces C2 positive cells when compared to SFM, whereas both NBI 31772 
and R3-IGF-I significantly increase C2 positive and total cell abundance when compared to SFM (*** = p < 0.01, ** = p < 0.05, * 
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Gene array screen using skewed IEC-18 cell composition to find potential phenotypic markers. Affymetrix rat gene chips were 
used to compare RNA from SFM and R3-IGF-I treated cells to find individual genes with significant fold changes – defined as 
greater than two fold more (A) or two fold less (B) with a p-value of less than 0.1 for the purpose of this screen. These were 
then compared with the fold changes from IGF-II analog and NBI 31772 to look for fold change trends that paralleled the 
changing cell composition (summarized in C as the percentage of crypt cells). The results are presented as upward arrows 
(strong positive correlations), upward dashed arrows (weak positive correlations), downward arrows (strong inverse correla-
tions) and downward dashed arrows (weak inverse correlations). The large asterisk points to an example where both direct 
receptor agonists resulted in a significant difference but NBI 31772 did not, suggesting a direct drug effect rather than an effect 
of cell composition – making this gene a less likely candidate. For smaller asterisks, *** = p < 0.01, ** = p < 0.05, and * = p < 
0.1.





<-3  <-2  <-1       >1   >2  > 3
IGF-II


























*Page 5 of 11
(page number not for citation purposes)
BMC Cell Biology 2005, 6:2 http://www.biomedcentral.com/1471-2121/6/2cells in SFM). 5-HT2A is present in high abundance within
paneth and neuroendocrine cell types but is absent within
small intestine crypt cells in vivo [11]. The cells that we
observed appeared to be in transition, going from IECs to
neuroendocrine-like cell morphology – with correspond-
ing increases in staining intensity. While still a very low
prevalence, the staining was quite intense in this small
subset and was not detected in any of the adjacent cells.
Double labeling confirms that C2 negative cells have 
diminished APC abundance
Double immunolabeling with overlay technique (using
C2 and actin antibodies) demonstrated that C2 negative
cells have a paucity of microvilli in comparison to C2 pos-
itive cells (Figure 6A). Additionally, double labeling with
C2 and APC demonstrated that C2 positive cells have uni-
form APC staining whereas C2 negative cell have variable
and overall diminished staining in comparison (Figure
6B). These experiments provide an objective demonstra-
tion that C2 positive cells retain the IEC phenotype
whereas C2 negative cell are undergoing transformation
(which is an obligatory step associated with the loss of
APC).
Discussion
In this manuscript we have taken advantage of an IEC
immunolocalization marker that we call C2 to demon-
strate two forms of cell fate divergence within IEC-18 cul-
ture. Using a combination of gene array screening and
immunolocalization, we found that C2 is lost in over half
the cells by the time of confluence and its loss is also asso-
ciated with a down regulation of the APC gene, decreased
APC protein abundance, decreased actin filament turn
over, and reduced microvillar density. In short, there is an
adenoma-like phenotype that fits with this genotype and
this fits well with what is known about the function of the
APC protein [12-15]. In addition, another cell genotype-
phenotype correlate was detected by screening out the 5-
HT2A gene and visualizing the cells that express its pro-
tein, i.e. neuroendocrine-like cells. These findings also fit
well with cell phenotypes known to express 5-HT2A in the
gut endoderm [11,16,17] and strongly argue against the
dogma that IECs persist as a single lineage prior to reach-
ing confluence.
While we think our findings have important implications
for the existing IEC literature, the more important aspect
of this manuscript may be in the methodology we have
piloted. In many ways, cell culture, whether primary or
immortalized, transformed or not, is by definition a
model in flux. The progenitor lineage that a researcher
starts with is rarely the hodge podge they end up with after
a limited number of passages and it is common, if not
expected that epigenetic drift will occur with each cell cul-
ture passage. However, what we describe in this
Immunolocalization of APC and 5-HT2A in IEC-18 cultureFigure 5
Immunolocalization of APC and 5-HT2A in IEC-18 culture. 
A: APC immunostaining parallels that of C2 and is found in 
crypt cell strands but is absent or scant in adjacent cells. B-
D: 5-HT2A immunostaining is absent in the majority of cells 
but is found in a few rare cells. On closer inspection, we 
found that there seemed to be a progressive increase in 
staining intensity that correlated with a morphologic transi-
tion away from IEC-18 cell morphology and towards that of a 
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a uniform trend in cell fate divergence – a trend that can
be modulated with IGF. Many if not most gut epithelial
cell lines are IGF (or high dose insulin) dependent for pro-
liferation and thus are potentially vulnerable to this bio-
logical confounder. It will remain to be seen if other
epithelial cell types have similar behaviors when exam-
ined in this fashion. Conversely, there is also a positive
light to our findings; IEC-18 cells could be a compelling
model for spontaneous adenomatous transformation
Double labeling overlay immunolocalization of C2 with either actin or APCFig r 6
Double labeling overlay immunolocalization of C2 with either actin or APC. Ai. C2 immunostaining of wet-prepped cells. Aii. 
C2 immunostaining in the same cells, overlaid with f-actin immunostaining. The proximal cores of actin-stained microvilli bun-
dles located on C2 positive cells are encircled, whereas there are either no or few microvilli on C2 negative cells. Bi. C2 
immunostaining of wet-prepped cells. Bii. C2 immunostaining in the same cells, overlaid with APC immunostaining. The dotted 
line divides C2 positive cells (below) from C2 negative cells (above). There is consistent APC staining in C2 positive cells, 
whereas there is variable and comparably reduced APC staining in C2 negative cells.
BiiBi
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ically competent progenitor prior to reaching confluence.
To our knowledge, no such model with this property has
been previously defined.
Our study has notable weaknesses and strengths. First, we
have identified two divergent cell fates but have only par-
tially characterized them because we were focused on
developing a viable screening methodology (hence the
ubiquitous use of the word "like" in this manuscript).
Second, we are using a rat gene array chip that has approx-
imately 9000 non-EST genes per chip. This is not an
exhaustive survey of the rat genome and it is possible that
there are other cell fates present in IEC-18 culture that we
did not detect. Third, our phenotype assays are based on
immunolocalization, which is a semi-quantitative tech-
nique with regards to assessing protein abundance.
However, in this case we are actually combining cell-to-
cell differences in protein abundance with distinguishing
morphologic characteristics (e.g. loss of microvilli, flat-
tening, bipolar shape, dendritic arbors, etc.) to delineate
the phenotypes between adjacent cells. In short, what we
are quantifying, in the case of adenoma-like cells, is the
percentage of cells with a given phenotype. For this pur-
pose, blinded immunolocalization is simple, quantitative
and exceedingly efficient. The combined methodologies
we chose result in a highly accurate technique for assess-
ing divergence and their specificity can be bolstered by
comparative studies of co-divergent markers (as we dem-
onstrated with C2 and APC). As for other positives, the
methodology is relatively rapid and can detect low preva-
lence phenotypes (as demonstrated by the anti-5-HT2A
antibody). Additionally, we have demonstrated that a
transcriptional marker is not required to create an effec-
tive screen. What is required, and what should probably
prompt a researcher to employ this methodology, is a
probe, a phenotype, or a pleiotropism that results in a
consistently heterogeneous and quantifiable pattern (as
C2 proved to be for us).
In closing, we point out one last caveat. Gene array inves-
tigation is an evolving science but there remain three
potential pitfalls for every new application: experimental
design flaws, data integrity issues and biological
misassumptions [18-20]. In this study, we used a well-
accepted screening principle (i.e. significant fold changes
within individual genes in response to a treatment); we
included a paired reference standard for each treatment
condition (the SFM control); we increased the screening
stringency by adding a requirement for parity in fold trend
in accordance with changing cell compositions; and then
confirmed our findings by phenotype assays. However,
we demonstrated that a small minority of neuroendo-
crine-like cells were still able to significantly alter the out-
come of our gene array screen (a possibility that we had
thought to be remote, given our assay's stringency). We
conclude that even low frequency epigenetic events can be
a serious biologic confounder of gene array studies in cell
culture.
Conclusions
We have demonstrated a novel methodology for detecting
and characterizing cell fate divergence in cell cultures
derived from a common progenitor. The majority of IEC-
18 cells are transformed into adenoma-like cells in SFM.
IGF agonists reduce the rate of transformation by driving
proliferation of the progenitor phenotype but do not pre-
vent it. We also detected a very low incidence of differen-




Rat ileal epithelial cells (IEC-18 – American Type Culture
Collection, Rockville, MD) from aliquots of passage num-
bers 6–8 were grown to confluence in DMEM with 10%
fetal bovine serum (FBS) and .1% insulin. The time period
for complete epithelial cell confluence was 24–48 hours.
Confluent cells were incubated for 72 hours in DMEM to
establish a serum free period either alone or with 10-6M
NBI 31772 (Calbiochem, San Diego, CA [21]), 0.5 × 10-
6M IGF-II analog, or 0.5 × 10-6M R3-IGF-I (Sigma, St. Louis
MO), as a means of boosting crypt cell proliferation. We
point out that crypt cells can be driven to proliferate
despite confluence whereas more differentiated epithelial
cell types are resistant to IGF-driven proliferation upon
reaching confluence. Alternatively, IEC-18 cells were
diluted to 1/8, 1/4 and 1/2 the original seeding density
and plated in DMEM with 10% FBS for 24 hours as a
means to evaluate cell fate divergence in the presence of
serum.
Western blots
Cell lysate samples were collected from 150 mm dishes,
washed with PBS and recovered in 700 uL of lysis buffer
by scraping the dish. Cells were spun down for 10 minutes
in a pre-chilled centrifuge. The supernatant was diluted
4:1 with loading buffer and run on 12 or 15% acrylamide
gels. After the gel had been transferred onto a nitrocellu-
lose membrane, 0.5% Ponceau S stain was applied to con-
firm equitable protein transfer across all lanes.
Western blot membranes were incubated in 5% milk
block for 1 hour at RT. Goat polyclonal primary antibody
for APC and 5-HT2A were applied for 1 hour at RT. Pri-
mary antibody was washed off with TBS-Tween and sec-
ondary antibody was placed on the membranes for one
hour, then washed again. ABC (Elite Series, Vector Labs)
was placed on the membrane for an hour and then
washed and visualized with SuperSignalPage 8 of 11
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was prepared per the manufacturer's instructions.
Gene array analysis
IEC-18 cells were treated and processed as described in
Cell Culture methods and then utilized to screen for spe-
cific cell fate markers. Total RNA was harvested for each
treatment condition in triplicate experiments and then
used for gene chip analysis per the manufacturer's proto-
col (rat gene chip # 230A, Affymetrix, Santa Clara, CA). All
available non-EST tags were searched within the R3-IGF-I
data set and those with significantly different fold changes
when compared to SFM cells were selected as potential
candidates for further analysis (for the purpose of a first
pass screen, a significant fold change was defined as a p
value < 0.1 and a greater than two fold increase or
decrease). To further refine the list of potential candidates,
the fold changes for NBI 31772 and IGF-II analog, which
had step-wise reductions in effects upon crypt cell prolif-
eration, were used to determine if there was a positive or
inverse trend between a selected gene's mRNA abundance
and crypt cell abundance. In this way, we sought to select
constitutively expressed genes, whose primary differences
in abundance would be due to differences in cell
composition. Our statistical test for determining signifi-
cance was a two-tailed paired t-test (provided as part of
the standard analysis by the University of Virginia Biomo-
lecular Research Facility and the Dept. of Health Evalua-
tion Sciences [22]).
Immunolocalization experiments
Immunolocalization in IEC-18 cells was performed for
IGFBP-2 (C2), f-actin, IGF receptor type 2 and villin as
well as two proteins that were screened out by our gene
array analysis (APC and 5-HT2A) in a minimum of three
separate experiments for each. In brief, the cells were fixed
Western blots of APC and 5-HT2A in IEC-18 cell lysatesFigure 4
Western blots of APC and 5-HT2A in IEC-18 cell lysates. Visualization of the appropriate sized band (and break down prod-
ucts) for APC is shown in lane A and 5-HT2A is shown in lane B.
APC (300 kD)
A B 
APC fragment (75 kD)
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Base, 6% 5M NaCl, 16% 1M Tris HCl) 5 times then put in
blocking solution (1% wt/vol BSA in DIG buffer) for 1
hour at room temperature. This was followed by a one-
hour incubation with goat polyclonal primary antibody
(all were obtained from Santa Cruz Biotechnology, CA;
specifically for the anti-actin antibody the product
number was sc-1615) in antibody diluent solution (5%
1M Tris HCl, 1% 1 M Tris Base, 9% NaCl, 3.3% Triton-X
100). Primary antibody was washed off with DIG × 5 and
secondary antibody (donkey anti-goat [Jackson Immu-
noresearch Labs, West Grove, PA]) was placed on the
slides for one hour. ABC (Elite Series, Vector Labs) was
prepared and applied per the manufacturer's instructions,
washed as above and visualized with DAB solution
(Sigma, St. Louis, MO) in parallel. The slides were coun-
terstained with hematoxylin, cover-slipped, photomicro-
graphed and representative images were chosen for
publication. With respect to the actin visualization, detec-
tion was performed such that colored precipitate was
observed under the microscope and stopped when stress
fibers and microvillus cores were evident and before the
high background of the total cell f-actin began to stain
efficiently. In the crypt cell quantification experiments, six
10X images were taken at random, printed on color paper
at maximum size, blinded, and all cells were assessed as
C2 positive or C2 negative and their means and standard
deviations calculated for each treatment condition.
C2 double labeling immunolocalization experiments
To objectively test our observations that C2 positive cells
have a distinctive colocalization pattern when compared
to C2 negative cells, C2 double labeling experiments with
f-actin and with APC were performed as overlay experi-
ments using digital microscopy. In brief, C2 immunolo-
calization was performed as described above except that a
grid was drawn on the wet mount slide, allowing digital
photomicrographs to be taken at 40X of C2 staining while
still covered with stop solution and then a second anti-
body, either for f-actin or APC was applied and the same
process repeated before being counter-stained with hema-
toxylin and cover-slipped. The same exact images were
then re-mapped using the grid and the stored digital
images were used for precise position verification. The
overlaid double-labeled image was then taken and con-
trasted to the original image to allow comparison of dif-
ferential localization of the two antigens.
Abbreviations
IGF, insulin-like growth factor; IGFBP-2, IGF binding pro-
tein-2; IGF-II analog, synthetic truncated IGF-II; R3-IGF-I,
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